Verona Pharma Plc's receivables is $87M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2025), VRNA shows a receivables of $87M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, VRNA's receivables is now $87M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Verona Pharma Plc is outperforming or lagging.
Tracking VRNA's receivables over time shows whether Verona Pharma Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $87M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Verona Pharma Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $87M) with ownership activity and broader fundamentals.
Verona Pharma Plc's receivables is $87M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.